Some Medicare Managed Care Plans Restrict Mammograms

Publication
Article
OncologyONCOLOGY Vol 13 No 6
Volume 13
Issue 6

Some Medicare managed care organizations (MCOs) are telling beneficiaries that they need to get a referral from one of the plan physicians before they can get a mammogram. But that is not what the law says. A woman can get an annual, routine

Some Medicare managed care organizations (MCOs) are telling beneficiaries that they need to get a referral from one of the plan physicians before they can get a mammogram. But that is not what the law says. A woman can get an annual, routine mammogram without any referral. William Scanlon, director of health financing and public health for the General Accounting Office (GAO), says that a study the GAO just did of 16 MCOs found that five of them erroneously stated the mammogram benefit.

And that wasn’t the only problem the GAO found after it combed through the plan documents and contracts for these MCOs. There were problems with the prescription drug benefit, too. Managed care organizations offer outpatient drugs—which are not available as part of Medicare fee-for-service—as an enticement to get people into managed care plans. Scanlon says that one plan stated in its contract with Medicare that it would pay the first $1,200 a year in name brand prescription expenses for each Medicare beneficiary. However, the literature given to potential members by the MCO stated that only the first $600 in name brand prescription expenses would be covered.

Those revelations came out at hearings held by the Senate Special Committee on Aging. Sen. Charles Grassley (R-Iowa), chairman of the committee, says inaccurate information given to beneficiaries by MCOs leads to appeals when benefit claims are then denied.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.